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Purpose. Changes in calbindin (CB) expression have been reported in patients with temporal lobe epilepsy (TLE) with controversial
implications on hippocampal functions. The aim of this study was to determine the CB immunoreactivity in hippocampal dentate
gyrus of patients who underwent epilepsy surgery for drug-resistant TLE with and without comorbid depression and/or memory
deficits. Methods. Selected hippocampal samples from patients with TLE who underwent epilepsy surgery were included. Clinical
and complementary assessment: EEG, video-EEG, MRI, psychiatric assessment (structured clinical interview, DSM-IV), and
memory assessment (Rey auditory verbal learning test, RAVLT; Rey-Osterrieth complex figure test, RCFT), were determined
before surgery. Hippocampal sections were processed using immunoperoxidase with the anti-calbindin antibody. The
semiquantitative analysis of CB immunoreactivity was determined in dentate gyrus by computerized image analysis (ImageJ).
Results. Hippocampal sections of patients with TLE and HS (n = 24) and postmortem controls (n = 5) were included. A
significant reduction of CB+ cells was found in patients with TLE (p < 0 05, Student’s t-test). Among TLE cases (n = 24),
depression (n = 12) and memory deficit (n = 17) were determined. Depression was associated with a higher % of cells with the
CB dendritic expression (CB-sprouted cells) (F 1, 20 = 11 81, p = 0 003, hp2 = 0 37), a higher CB+ area (μm2) (F 1, 20 = 5 33,
p = 0 032, hp2 = 0 21), and a higher optical density (F 1, 20 = 15 09, p = 0 001, hp2 = 0 43) (two-way ANOVA). The GAF scale
(general assessment of functioning) of DSM-IV inversely correlated with the % of CB-sprouted cells (r = −0 52, p = 0 008) and
with the CB+ area (r = −0 46, p = 0 022). Conclusions. In this exploratory study, comorbid depression was associated with a
differential pattern of CB cell loss in dentate gyrus combined with a higher CB sprouting. These changes may indicate granular
cell dysmaturation associated to the epileptic hyperexcitability phenomena. Further investigations should be carried out to
confirm these preliminary findings.
1. Introduction
Depression disorders are the most common psychiatric diag-
nosis in persons with drug-resistant temporal lobe epilepsy
(TLE). The prevalence rate oscillates between 30 and 35%
in population-based studies, reaching the highest prevalence
(50%) at specialized epilepsy centers [1]. Depression disor-
ders have been associated with a worse quality of life and a
poorer treatment response to both pharmacological and
surgical treatments [2–6]. Additionally, population-based
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studies described that a positive history of depression was
more frequently found among patients with epilepsy onset
indicating a bidirectional relationship [7].
The complex underlying pathogenic mechanisms of
this association are still unknown; however, it has been
proposed that epileptic phenomena may negatively affect
dentate gyrus granular cell neuroplasticity, with implications
on hippocampal-dependent functions, facilitating cognitive
impairments (episodic memory) and emotional alterations
(depression and stress vulnerability) [8–12]. Hippocampal
sclerosis (HS) is the most frequent (60-70%) neuropatholog-
ical finding in patients with drug-resistant TLE and is charac-
terized by a loss of pyramidal neurons in CA1-4 of the
hippocampus. Dentate gyrus layers are also affected in a var-
iable proportion of patients ranging from 50% to 80% in
patients with chronic epilepsy, with even higher rates reach-
ing 100% in reports from TLE patients with hippocampal
sclerosis [13, 14]. Dentate gyrus pathology is characterized
by neuronal loss, granular cell dispersion, ectopic localiza-
tion, aberrant synapsis, and abnormal sprouting of mossy
fibers [13–17]. Furthermore, a reduction of dentate gyrus
neuroplasticity with lower rates of newly formed cells has
been found in experimental models of chronic epilepsy
[18–20] and in human patients with drug-resistant epilepsy
[21–24]. In this line, in the previous studies performed by
our group, we found a reduction of the newly formed cell
neuronal markers, doublecortin and nestin, in dentate gyrus
from adult patients with chronic TLE with comorbid psychi-
atric and cognitive disorders [25, 26].
Calbindin is a calcium-binding protein preferentially
expressed in excitatory granular cells of dentate gyrus layers
and constitutes a marker of granule cell maturity [27–29].
The reduction of the calbindin (CB) (28 kD) expression in
dentate gyrus constitutes an early and common morpholog-
ical sign observed in animal models of epilepsy [30, 31] and
in human TLE [27, 28, 32, 33] with and without hippocampal
sclerosis [34]. It has been observed in the animal models that
both situations, CB deficiency and CB overexpression in
dentate gyrus, may reduce LTP (long-term potentiation)
and memory [35, 36]. Studies of the calbindin expression
in the dentate gyrus from patients with TLE and hippo-
campal sclerosis qualitatively described different patterns
[17, 33]: the pattern 1, characterized by a reduced number
of CB+ granular cells predominantly among basal layers
with a higher proportion of strong CB+ cells located in
outer layers, with CB-positive sprouted fibers and ectopic
localization (inner molecular layers); the pattern 2 (normal)
observed in normal postmortem samples and in some TLE
patients, characterized by a homogeneous pattern; and the
pattern3with ahomogeneous reductionofCB+granular cells.
Only a few studies determined the clinical and patholog-
ical correlations between CB alterations and memory in
patients with epilepsy with controversial results [32, 33];
however, how these alterations are related with emotional
disturbances and depression has not been described. The
aim of this study was to analyze the expression of CB immu-
noreactivity, a marker of mature granular cells. We studied
the hippocampal dentate gyrus layers of patients with drug-
resistant TLE who underwent epilepsy surgery, with and
without comorbid psychiatric depression and/or memory
deficits before epilepsy surgery.
2. Methods
2.1. Study Design and Patient Selection. This study was per-
formed at the Epilepsy Center of the Ramos Mejía Hospital
and El Cruce Hospitals and at the Institutes ENyS-IBCN-
CONICET, Buenos Aires, Argentina. The Epilepsy Center
is the main reference public center in the country for epilepsy
surgery and assists a population with the high rates of drug-
resistant epilepsy (70%-80%) [37, 38].
This study was conducted with the approval of the Ethics
Committee of Ramos Mejía and EL Cruce Hospitals, in
accordance with the ethical standards laid down in the 1964
Declaration of Helsinki, and all the subjects’ submitted the
informed consent for participating in the study.
2.1.1. Inclusion Criteria. We selected hippocampal samples
obtained from patients who underwent epilepsy surgery for
temporal lobe drug-resistant epilepsy (TLE) [14]. Only
patients who had completed the psychiatric assessment pro-
tocol and neuropsychological assessment before surgery and
who signed the approved informed consent for participation
were included [39, 40].
Selected samples from patients with TLE were grouped
according to categorical variables: (1) depression factor: it
was considered positive when patient met the criteria for at
least one current or past interictal episode of major depres-
sion and/or other depression disorders, codified in axis I of
DSM-IV using SICD I (dysthymia, major depression with
or without psychotic symptoms, and/or recurrent depres-
sion). (2) Memory factor: memory was pondered impaired
when Rey auditory verbal learning test (RAVLT) Spanish
version and/or Rey-Osterrieth complex figure test (RCFT)
scores were >2 of standard deviation from normal data
adjusted by age and gender according to Lezak [41].
2.1.2. Exclusion Criteria. The exclusion criteria were the
present or past history of other chronic interictal psychiatric
disorders (nonaffective disorders) codified in other sections
in axis I of DSM-IV (i.e., chronic psychosis) and patients
with mental retardation (IQ < 70 and/or attendance to a
special school).
2.2. Diagnosis of Drug-Resistant TLE. Prior to surgery, all
patients were evaluated according to the Epilepsy Center
diagnosis protocol, specially designed for patients with resis-
tant epilepsy and surgical candidates. This protocol includes
the clinical examination by trained neurologists and comple-
mentary studies to confirm the temporal lobe origin of the
epileptogenic zone by interictal EEG, video-EEG monitoring,
magnetic resonance imaging (MRI) with a temporal lobe epi-
lepsy protocol, and neuropsychological assessment [37, 38].
2.3. Video-EEG Evaluation. All patients included in this
study underwent video-EEG evaluation in order to confirm
the epileptogenic zone and to determine the possibility of
epilepsy surgery. For long-term EEG monitoring, a Stellate-
Bioscience EEG machine at a 200Hz sample rate was used.
2 Behavioural Neurology
All ictal recordings were obtained using the international
10–20 system with the addition of temporal electrodes of
the 10–10 system. Referential montages as well as longitu-
dinal bipolar and transverse bipolar montages were used
for the analysis.
2.4. Magnetic Resonance Image (MRI). Magnetic resonance
image protocol used was sagittal T1-weighted fluid-
attenuated inversion recovery (FLAIR) T1 FFE 3D acquisi-
tion, perpendicular to the long axis of the hippocampus,
and T2-weighted axial, parallel to the long axis of the hippo-
campus. All patients included in this study met the image cri-
teria for HS diagnosis: atrophy, hypointense in T1W and IR,
hyperintense in T2W and FLAIR, and alteration of the inter-
nal structure of the hippocampus [42].
2.5. Neuropsychological Assessment. All patients underwent a
neuropsychological assessment protocol before surgery (usu-
ally 6 months to one year before surgery), provided by
trained specialists. In this study, verbal memory was deter-
mined using the Rey auditory verbal learning test (RAVLT),
Spanish version [43]. It consists of reading a list of words in
five different trials, recovering the immediate memory and
differed memory, and recognition in each trial. For visual
memory, the Rey-Osterrieth complex figure test (RCFT)
was determined. This nonverbal test consists of presenting
a visual design that patients had to copy first and reproduce
immediately after the visual presentation (immediate recall)
and after 30 minutes (differed recall). Considering there is
no regional normative data for Argentinian population,
international data was used to compare our results [41].
2.6. Psychiatric Assessment.All patients included in this study
underwent a complete psychiatric assessment prior to
surgery (usually 6 months to one year before surgery). Psy-
chiatric assessment was performed routinely by trained psy-
chiatrists according to a standardized protocol specially
designed for patients with epilepsy [40, 44]. Psychiatric his-
tory was obtained from each patient and relatives, comple-
mented by information from relatives. The psychiatric
semiology of the witnessed examination was supplemented
with the structured clinical interview (SCID) Spanish version
for DSM-IV axis I diagnoses SCID-I and SCID II for person-
ality disorders [45, 46]. Additionally, all patients were
assessed according the global assessment of functioning
(GAF) of DSM-IV and to the Beck depression scale. The
GAF is a 100-point tool rating overall psychological, social,
and occupational functioning in relation to psychiatric
assessment, included in the DSM-IV in the section on multi-
axial assessments (axis V of DSM-IV) [47]. The interviews
were carried out in approximately 2 to 3 hours. Beck depres-
sion inventory II, Spanish version, was also administered to
quantify depression symptoms (33). Beck inventory was
added to the protocol at the Epilepsy Center after 2010, and
only the patients included in the last period had completed
this item prospectively.
2.7. Tissue Processing and Pathological Diagnoses. The surgi-
cal piece was fixed in formalin for 7 days. Tissue blocks
(thickness: 5mm) were made following coronal planes and
were embedded in paraffin for storage. For this study, com-
pleted coronal hippocampal sections localized at the anterior
medial region of the hippocampus body were cut at 7μm
with a microtome, stretched in water, mounted on slides,
deparaffined in xylene, and hydrated and stained with
haematoxylin-eosin and thionin stain. Hippocampal samples
were studied by a trained neuropathologist with routine tech-
niques including haematoxylin-eosin and thionin stain, and
additionally, some samples were stained with immunohisto-
chemistry with anti-NeuN and anti-GFAP to determine the
pathological diagnosis [14]. Archival material of the normal
postmortem hippocampus donated from autopsies to the
pathology department for research was included. Samples
were selected andmatched by gender and age, and the sample
free from neurological injury, drug and/or alcohol depen-
dency, and suicidal evidences was simultaneously processed
as controls.
2.7.1. Immunohistochemistry. After deparaffinization, sec-
tions were treated according to the following procedure: a
15min wash in distilled water, then an incubation in a micro-
wave at 100°C twice for 5min in a citric acid solution
(0.1mol/L citric acid monohydrate and 0.1mol/L trisodium
citrate dihydrate), pH6.0, and after that a 2-fold 5min wash
in phosphate-buffered saline (PBS); the sections were incu-
bated for 30min in 0.5% (v/v) hydrogen peroxide in ethanol
to quench endogenous peroxidases. Afterwards, they were
incubated overnight in a humid chamber at 4°C with rabbit
polyclonal anti-calbindin (28 kD) Millipore cat # AB1778,
1/500 in PBS Triton X-100, and 0.1% (w/v) sodium azide.
Additionally, other sections were incubated with the mouse
monoclonal antibody, anti-NeuN Millipore cat # MAB377
1/200, and others with rabbit polyclonal anti-GFAP Dako
(1/200) cat # 300742EFG. After that, a biotinylated secondary
anti-mouse/rabbit antibody (1 : 1000, Vector Laboratories)
followed by 30min in Vectastain Elite ABC solution (Vector
Laboratories) was incubated at room temperature. The com-
plex was detected using the supersensitive multilink-
HRP/DAB kit from Bio-Genex cat # QD000-5L following
the vendor’s procedure, and haematoxylin staining was
added at the end of the procedure. Controls omitting the pri-
mary and the secondary antibody were determined [26].
2.7.2. Microscope Image Analysis. Sections immunostained
with CB were examined in detail for each case. The images
were acquired by a SONY Power HAD 3CCD colour video
camera system from a Zeiss Axiophot microscope. Micro-
photograph images (20x) were captured from different areas
along the transversal axis of hippocampal dentate gyrus and
were digitalized with a resolution of 1280-960 pixels. All
images (five images per case) were captured under identical
lighting and magnification conditions. The semiquantitative
measurements of the microphotographs including all dentate
gyrus layers by field (molecular layer, granular cell layer, and
polymorphic layer including those granular cells dispersed in
the molecular layer) were determined. The semiquantitative
examination of the CB staining in dentate gyrus was deter-
mined by single-cell analysis using the computerized image
analysis program, ImageJ. Two independent and blinded
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observers made the measures. The parameters analyzed were
the following: (a) calbindin-positive cells (CB+) and CB-
negative cells (CB-), (CB- was considered for haematoxylin-
positive nucleus) by field were counted. The proportion of
CB+ cells was expressed as the percentage of the entire gran-
ule cell population (CB+ and CB-) counted by field. (b) The
mean of CB+ reactive surface (reactive area of soma) was
determined for CB+ cells (μm2). (c) The staining intensity
(optical density) was calculated using the mean gray value
(MGV) function of the ImageJ. It was calculated for each
CB+ cell (soma), and the background was subtracted
(inverted measures). The MGV of the background was calcu-
lated using 3 measures by photo. The final result indicates a
direct measure of the intensity of the immunoreaction. (d)
The proportion of CB+ cells with soma and dendritic CB
expression (sprouted cells) was expressed as a percentage of
the entire CB+ cells counted. (e) The mean length of the
CB+ dendritic processes was measured (CB+ processes
emerging from the soma > 2 μm of length were considered).
The parameters described in the point (b) and point (c) were
only analyzed in TLE samples, since the postmortem period
with different times of fixation may modify the results.
2.7.3. Statistical Analysis. Normality distribution was deter-
mined using the Shapiro-Wilk test. Two-tailed significant
levels were fixed at p < 0 05, (1-βpower ≥ 0 80). Descriptive
statistics were performed, and the chi-square test was used
to analyze qualitative variables. The Student t-test and the
two-way ANOVA were applied when normal distribution
was found and nonparametric tests (Mann-Whitney) were
applied when distribution was not normal (Shapiro-Wilk
test < 0 05). The effect size was calculated using partial eta
squared (hp2), and the presence of significative interactions
was determined. Pearson correlation coefficients were ana-
lyzed among quantitative variables. A computational pro-
gram for Windows (SPSS 22 version) was used to perform
the statistical analysis.
3. Results
Hippocampal sections of the selected patients with TLE and
HS consecutively operated between 2006 and 2014 (n = 24)
and postmortem controls (n = 5) were included. Among
TLE cases (n = 24), depression (n = 12) and memory deficit
(n = 17) were determined during the presurgical assessment
protocol. Memory deficits were presented in 66% (n = 8) of
patients with TLE and depression and in 75% (n = 9) among
patients with TLE without depression (p = 0 65, chi-square
test). Demographic, clinical, psychiatric, neuropsychological,
and neuropathological data of patients are shown in Table 1.
Archival material obtained from the normal postmortem
hippocampus matched by gender and age, free from neuro-
logical injury, drug, and/or alcohol dependency, was simulta-
neously processed as controls. The time of autopsy never
exceeded 6 hours. Five postmortem controls (2 male, 3
female, mean age 41 ± 18) (p > 0 05, chi-square test compar-
ing age and sex with the TLE group) were included. The
causes of death were cardiopathy (n = 2) and nonencephalic
trauma (n = 3).
Figure 1 shows dentate gyrus from postmortem con-
trols and TLE patients, viewing dentate gyrus dispersion
and cell loss in TLE patients. Figure 2 shows dentate gyrus
CB immunoreactivity and the different patterns described
by Martinian et al. [33]. Qualitative examination of den-
tate gyrus patterns showed a normal pattern (pattern 2)
in postmortem controls (Figure 2(a)), a lower CB+ cell
density among dentate gyrus layers (pattern 3) in TLE
patients (Figures 2(b)–2(e)), and a reduced number of
CB+ granular cells predominantly among basal layers with
a great proportion of strong CB+ cells located in outer
layers with ectopic localization (inner molecular layers)
(pattern 1) in TLE+D (Figures 2(f)–2(i)).
The CB semiquantitative measurements (% of CB+
cell counting and % of CB+-sprouted cells) were com-
pared between the TLE samples and postmortem controls
using Student’s t-test (normal distribution, Shapiro-Wilk
test > 0 05) and/or Mann-Whitney test (Shapiro-Wilk
test < 0 05). TLE samples showed a reduction in the per-
centage of CB+ cells by field (20x) (x = 41 96, SD = 14 47)
compared with controls (x = 68 52, SD = 8 25) (t = −3 93,
p = 0 001) (Student’s t-test). TLE samples showed a
higher percentage of cells with soma and dendritic CB+
expression (sprouted cells), TLE (mean rank = 17 38, x =
9 08, SD = 6 48) compared with controls (mean rank = 3 6,
x = 0 78, SD = 0 33) (U = 3, p = 0 001) (Mann-Whitney),
and longer CB+ dendritic processes (μm), TLE (mean
rank = 16 92, x = 10 91, SD = 7 50) versus controls (mean
rank = 5 8, x = 3 96, SD = 1 50) (U = 14, p = 0 005)
(Mann-Whitney) (Figure 3).
In the second exploration, we studied the association
of depression and memory deficits in TLE (n = 14) and
inTLE+D(n = 12) cases, in relation to theCBsemiquantitative
findings (% of CB+ counting, % of CB-sprouted cells, MGV,
CB+ area, and length of CB+-sprouted processes) using the
two-way ANOVA (Shapiro-Wilk test p > 0 05). Depression
factorwas associatedwith ahigher%ofCB+cellswithCBden-
dritic expression (CB+-sprouted cells) (F 1, 20 = 11 81, p =
0 003, hp2 = 0 37), a higher CB+ area (μm2) (F 1, 20 = 5 33,
p = 0 032, hp2 = 0, 21), and a higher optical density (MGV)
(F 1, 20 = 15 09, p = 0 001, hp2 = 0 43). Memory deficits
were associated with a lower reduction of the % of CB+ cells
comparing patients with normal memory (F 1, 20 = 7 68,
p = 0 012, hp2 = 0 28). No significant differences were
observed in the % of CB+ cells regarding depression
(F 1, 20 = 0 145, p = 0 70, hp2 = 007) (Figure 4). No sig-
nificant differences were observed comparing memory deficit
with CB+ MGV (F 1, 20 = 0 12, p = 0 72, hp2 = 0 006), with
% of cells with CB+ dendritic expression (F 1, 20 = 0 29,
p = 0 59, hp2 = 0 014), and neither with CB+ area (μm2)
(F 1, 20 = 0 92, p = 0 35, hp2 = 0 04). No significant inter-
actions were observed between the factors. Additionally, no
parametric comparison between TLE+D and TLE was deter-
mined for the length of CB+ processes. Longer CB+ processes
(μm) were also more frequently observed in TLE+D patients
(mean rank = 16 42, x = 14 68, SD = 8 55) as compared
with TLE without depression (mean rank = 8 58, x = 7 1,




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Pearson correlations were determined between clinical
variables of epilepsy including psychiatric and cognitive
variables, with CB expression. Age of epilepsy onset
inversely correlated with the length of CB sprouting
(r = −0 48, p = 0 17) and the same tendency but no signif-
icant was observed between the age of epilepsy onset and
the % of CB+-sprouted cells (r = −0 32, p = 0 13). Age of
epilepsy onset and % of CB+ cells were correlated
(r = 0 33, p = 1 11). The % of sprouted cells showed a high
correlation with the length of CB+ sprouting (r = 0 76,
p = 0 0 001), the reactive area (r = 0 70, p = 0001), and the
MGV (r = 0 68, p = 0 0001).
In relation to psychiatric variables, the GAF scale (a
quantitative measure of global functioning according to
psychiatric morbidity) inversely correlated with the % of
CB-sprouted cells (r = −0 52, p = 0 008) and with the CB+
surface area (r = −0 46, p = 0 022). No significant correla-
tions were found with MGV (r = −0 33, p = 0 14)
(Figure 5). The Beck inventory, which determines the current
status of depression severity, showed no significant correla-
tions between the CB+ surface area (r = 0 28, p = 0 27), the
% of CB+ cells (r = 0 38, p = 0 13), the MGV (r = 0 395, p =
0 130), and the % of CB+-sprouted cells (r = 0 28, p = 0 29)
(only 16 patients completed this scale).
Regarding cognitive variables, the z-scores of verbal and
visual memory tests were analyzed ipsilateral for the epileptic
focus. In the cases with a right focus, visual memory was con-
sidered, while in the cases with a left focus, verbal memory
was considered. No significant correlations were found
between the z-scores and the CB+ area (r = −0 01, p = 0 93),
the % of CB+ cells (r = 0 20, p = 0 34), the MGV
(r = −0 27, p = 0 212), and the % of CB+-sprouted cells
(r = −0 04, p = 0 84). A tendency but no significant inverse
correlation was found between the Beck inventory scores
and the z-scores of verbal and visual memory tests
(r = −0 39, p = 0 13).
4. Discussion
In this preliminary study, we found an important reduction
of CB+ cell counting in dentate gyrus from TLE patients
comparing controls similarly to other authors [27, 28, 32–
34]. Additionally, we observed a differential pattern of CB
immunoreactivity with a higher proportion of larger and
stronger CB+ cells with sprouting processes projecting into
the molecular layer in TLE patients with comorbid depres-
sion, especially in the most severe depressive patients with
lower GAF scores. Comparable to these features, Ábrahám
et al. described strong CB+ cells located at the outer layers
of dentate gyrus in patients with TLE [34]; then, Martinian
et al. described the pattern 1 of CB immunoreactivity charac-
terized by a reduction of CB+ granular cells predominantly
among basal layers with a great proportion of strong CB+
cells located in outer layers [33]. Furthermore, Thom
described the CB immunoreactive pattern with the sprouting
of CB+ granular cells, as a common occurrence in HS, and
highlighted the importance of granular cell pathology to
understand epilepsy comorbidities [17]. This pattern 1 was
associated with a major extent of granular cell dispersion





















Figure 1: Hippocampal dentate gyrus from controls and patients with TLE and hippocampal sclerosis.
6 Behavioural Neurology
may indicate local higher hyperexcitability [17, 33, 48].
Hyperexcitability has been considered a factor that might
enhance depression behavior in animal models of epilepsy
and depression [3, 9], and Kandratavicius et al. found an
enhanced mossy fiber sprouting using Neo-Timm staining
in patients with epilepsy and comorbid depression [49].
It has been proposed that disrupted granule cell neuro-
plasticity in epilepsy may contribute to both hyperexcitability
and neuropsychiatric illness favoring to behavioral and cog-
nitive alterations [3, 9, 10, 11, 49]. The acute epileptogenic
insult increases the production of new formed cells with
aberrant sprouting, abnormal maturation, and ectopic inte-
gration into dentate gyrus layers contributing to hyperexcit-
ability [9, 50]. However, this initial event followed by
chronic epilepsy instauration (recurrent seizures) may affect
cell survival resulting in a reduced number of mature adult
neurons at the end of the process [12, 18, 19, 23, 25, 26],
which may also contribute to enhance dentate gyrus excit-
ability [51]. It has been recently reported that mature cells
activate local GABAergic circuits favoring cellular inhibition;
indeed, the low grade of maturity of granular cells may con-
tribute to reduce hippocampal excitability [51, 52].
CB expression in dentate gyrus granular cells is consid-
ered a marker of granular cell maturity; thus, alterations in
CB expression patterns may indicate a dysmaturation pro-
cess [17, 29, 33]; however, the specific role of CB in granular
cells is still controversial. CB is a calcium-binding protein
that is usually located in neocortex in GABAergic interneu-
rons, but in dentate gyrus, CB predominates in glutamatergic
granular cells and is expressed in the later stages of hippo-
campal neurogenesis denoting the initiation point of synap-
togenesis (first step of the trisynaptic circuit receiving the
perforant path from the entorhinal cortex) [29, 50]. CB con-






























Figure 2: Hippocampal sections from postmortem control (a) and TLE with HS (b–i). PL: polymorphic layer; ML: molecular layer; GL:
granular cell layer. (a) Qualitative analysis of postmortem control shows homogeneous CB+ granular cell morphology and staining and
the absence of GL dispersion and/or ectopic localization. (b–e) Qualitative examination of dentate gyrus sections from TLE patients
showed lower CB+ cell density among all dentate gyri (cases 5, 6, 14, and 15 of Table 1). (f–i) Qualitative examination of dentate gyrus
sections from TLE+D patients showed a pattern with a reduced number of CB+ granular cells predominantly among basal layers (basal
granule cells are predominantly CB negative), with a great proportion of strong CB+ cells located in outer layers, with CB-positive
arborization (CB+ sprouted cells), ectopic localization (inner molecular layers), higher CB+ content (higher staining intensity and CB+
area), and longer apical CB+ sprouted fibers projecting into ML (arrows). Basal CB+ sprouted processes are also observed (cases 20, 21,

































Figure 3: Semiquantitative analysis of dentate gyrus CB immunoreactivity observed in TLE patients and postmortem controls.
Postmortem controls showed a significant higher number of CB+ cells, with a significant reduction of CB+ sprouted cells comparing





























































Memory normal Memory deficit
Depression
No depression
Figure 4: Patients with normal memory showed a lower counting of CB+ cells comparing with TLE patients with memory deficits (∗p < 0 05).
Depression factor was significantly associated with higher % of CB+ cells with positive dendritic processes (sprouted cells), a higher CB+
























































Figure 5: The GAF (global assessment of functioning, DSM-IV) inversely correlated with the % of CB sprouted cells (r = −0 52, p = 0 008),
with the CB+ area (r = −0 46, p = 0 022), and with the optical density (mean gray value) (r = −0 33, p = 0 14).
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and was proposed as a neuromodulator marker essential
to hippocampal well functioning [33]; nevertheless, the
physiological role of CB in granular cells has not been
clearly determined. In addition, several studies reported a
neuroprotective activity through buffering intracellular cal-
cium; these findings were mostly determined in the cere-
bral cortex, and on the contrary, the decreasing CB
might protect these cells from excitotoxicity in granular
cells of dentate gyrus contributing to the resistance of sur-
vival [53]. In this line, it has been observed that an over-
expression of CB in DG neurons may disrupts LTP (long-
term potentiation) affecting the CB homeostatic role in
synaptic plasticity [54]. Similarly, an overexpression of
CB in dentate gyrus layers increased mossy fiber excitatory
postsynaptic potentials and impaired spatial navigation in
experimental models [36].
Overall, these findings have supported the theory that
bidirectional facilitation mechanisms are involved between
hyperexcitabilities due to seizures and depression [3, 55,
56]. In chronic epilepsy, recurrent neuronal hyperexcitability
may reduce neuroplasticity and neurogenesis contributing to
depressive behavior probably enhancing stress vulnerability
mechanisms [9, 10, 19, 57, 58]. Additionally, chronic stress
and glucocorticoids affect dentate gyrus layer functioning,
enhancing neuronal excitability and reducing hippocampal
neuroplasticity and neurogenesis favoring both depression
and hyperexcitability [59–63]. Similar to epilepsy, depres-
sion, and chronic stress, cause plastic remodeling in the hip-
pocampal networks inducing a loss of dendritic spines at
CA3 layers and reducing NG in dentate gyrus [64]. However,
this process is reversible and is principally mediated by glu-
cocorticoids acting throughout mineralocorticoid/glucocor-
ticoid receptors and glutamate [61, 65]. These mechanisms
have been involved in the hippocampal volume loss associ-
ated to major depression [62]. Similar to epilepsy, in chronic
stress and depression models, cortisol and excitatory amino
acids play a principal role in exerting a potential deleterious
effect in the brain inducing granular cell hyperexcitability,
lower neuroplasticity, and higher neuroinflammation
response [66–70]. According to these findings, stress
response system activation during patient’s life may potenti-
ate epileptic hippocampal pathogenic mechanisms and den-
tate gyrus hyperexcitability facilitating and enhancing stress
vulnerability leading to depression.
Regarding memory, a CB overexpression has been associ-
ated with lower hippocampal-dependent memory [36] and,
on the other side, CB loss has been also observed after
chronic stress and was associated with memory deficits in
experimental models [54]. Furthermore, the reduction of
mature granular cells in dentate gyrus has been related to a
poorest cognitive performance in epileptic patients [71].
Additionally, studies using human cells isolated from surgical
material of patients with resistant epilepsy found a low prolif-
erative capacity in subjects with more severe learning and
memory deficits [12]. A few studies determined CB dentate
gyrus expression and cognitive performance in patients with
epilepsy [32, 33] showing controversial results. Martinian
et al. qualitatively described the three different patterns of
CB immunoreactivity mentioned before, but they did not
found any differences comparing the patterns of CB expres-
sion in relation to memory deficits [33]; however, Karádi
et al. found a correlation between CB granular cell loss and
verbal scores but not with visual memory scores [32]. The
controversial results may be due to the different methods
used for clustering data. In this study, the CB overexpression
pattern with a higher CB sprouting was associated with
depression while the reduction of CB counting was higher
in patients with normal episodic memory (both hippocampal
dependent memories verbal and visual were normal). Further
analysis should be made to confirm these controversial find-
ings regarding memory.
Limitations of this study must be mentioned. First, this is
a small and exploratory study; further and larger investiga-
tions using other biomarkers and double immune stains
must be performed to confirm the mechanisms involved in
these preliminary findings. Furthermore, depression and
memory deficits were only analyzed in patients with TLE
under chronic treatment with different kinds of drugs
including antidepressants and antiepileptic treatments;
indeed, the conclusions of this study must be referred to
this special population. In this study, we did not analyze
the postsurgical outcome, but this will be an interesting
approach for future studies.
5. Conclusions
In this exploratory study, comorbid depression was associ-
ated with a different pattern of CB cell loss in dentate gyrus
with CB overexpression among outer granular cell layers.
These changes may indicate granular cell dysmaturation
associated to the epileptic hyperexcitability phenomena,
supporting the bidirectional relationship theory described
between depression and epilepsy. Nevertheless, we cannot
know if these are adaptive changes and the functional
meaning and/or the functional consequences of these find-
ings. Granular cell pathology constitutes a possible com-
mon basis to understand the neurobiological mechanisms
involved in the psychiatric comorbidities of epilepsy. Fur-
ther and larger investigations should be made to confirm
these preliminary findings.
Data Availability
The data used to support the findings of this study are avail-
able from the corresponding author upon request.
Ethical Approval
We confirm that we have read the journal’s position on issues
involved in ethical publication and affirm that this report is
consistent with those guidelines.
Conflicts of Interest
None of the authors has any conflict for this research.
9Behavioural Neurology
Acknowledgments
We thank all participants and collaborators of this study, all
the team of the Epilepsy Center of Ramos Mejía Hospital
and El Cruce Hospital, Laura Ruth Guelman, Clara Prover-
bio, and Erica Escobar, for their valuable help. This work
was financed by the PIDC 2012-FONCyT and CONICET.
References
[1] J. F. Tellez-Zenteno, S. B. Patten, N. Jetté, J. Williams, and
S. Wiebe, “Psychiatric comorbidity in epilepsy: a population-
based analysis,” Epilepsia, vol. 48, no. 12, pp. 2336–2344, 2007.
[2] R. Dias, L. M. Bateman, S. T. Farias et al., “Depression in epi-
lepsy is associated with lack of seizure control,” Epilepsy &
Behavior, vol. 19, no. 3, pp. 445–447, 2010.
[3] A. M. Kanner, S. C. Schachter, J. J. Barry et al., “Depression
and epilepsy: epidemiologic and neurobiologic perspectives
that may explain their high comorbid occurrence,” Epilepsy
& Behavior, vol. 24, no. 2, pp. 156–168, 2012.
[4] A. M. Kanner, “Is depression associated with an increased risk
of treatment-resistant epilepsy? Research strategies to investi-
gate this question,” Epilepsy & Behavior, vol. 38, pp. 3–7, 2014.
[5] L. Scévola, M. Sarudiansky, A. Lanzillotti, S. Oddo, S. Kochen,
and L. D'Alessio, “To what extent does depression influence
quality of life of people with pharmacoresistant epilepsy in
Argentina?,” Epilepsy & Behavior, vol. 69, pp. 133–138, 2017.
[6] R. A. Cleary, S. A. Baxendale, P. J. Thompson, and J. Foong,
“Predicting and preventing psychopathology following tempo-
ral lobe epilepsy surgery,” Epilepsy & Behavior, vol. 26, no. 3,
pp. 322–334, 2013.
[7] D. C. Hesdorffer, L. Ishihara, L. Mynepalli, D. J. Webb, J. Weil,
andW. A. Hauser, “Epilepsy, suicidality, and psychiatric disor-
ders: a bidirectional association,” Annals of Neurology, vol. 72,
no. 2, pp. 184–191, 2012.
[8] P. Bielefeld, E. A. van Vliet, J. A. Gorter, P. J. Lucassen, and
C. P. Fitzsimons, “Different subsets of newborn granule cells:
a possible role in epileptogenesis?,” The European Journal of
Neuroscience, vol. 39, no. 1, pp. 1–11, 2014.
[9] M. S. Hester and S. C. Danzer, “Hippocampal granule cell
pathology in epilepsy - a possible structural basis for comor-
bidities of epilepsy?,” Epilepsy & Behavior, vol. 38, pp. 105–
116, 2014.
[10] S. C. Danzer, “Depression, stress, epilepsy and adult neurogen-
esis,” Experimental Neurology, vol. 233, no. 1, pp. 22–32, 2012.
[11] R. Shin, K. Kobayashi, H. Hagihara et al., “The immature den-
tate gyrus represents a shared phenotype of mouse models of
epilepsy and psychiatric disease,” Bipolar Disorders, vol. 15,
no. 4, pp. 405–421, 2013.
[12] R. Coras, F. A. Siebzehnrubl, E. Pauli et al., “Low proliferation
and differentiation capacities of adult hippocampal stem cells
correlate with memory dysfunction in humans,” Brain,
vol. 133, no. 11, pp. 3359–3372, 2010.
[13] I. Blümcke, I. Kistner, H. Clusmann et al., “Towards a clinico-
pathological classification of granule cell dispersion in human
mesial temporal lobe epilepsies,” Acta Neuropathologica,
vol. 117, no. 5, pp. 535–544, 2009.
[14] I. Blümcke, M. Thom, E. Aronica et al., “International consen-
sus classification of hippocampal sclerosis in temporal lobe
epilepsy: a Task Force report from the ILAE Commission on
Diagnostic Methods,” Epilepsia, vol. 54, no. 7, pp. 1315–
1329, 2013.
[15] F. Cendes, A. C. Sakamoto, R. Spreafico, W. Bingaman,
and A. J. Becker, “Epilepsies associated with hippocampal
sclerosis,” Acta Neuropathologica, vol. 128, no. 1, pp. 21–37,
2014.
[16] I. Blümcke, M. Thom, E. Aronica et al., “The clinicopathologic
spectrum of focal cortical dysplasias: a consensus classification
proposed by an ad hoc Task Force of the ILAE Diagnostic
Methods Commission,” Epilepsia, vol. 52, no. 1, pp. 158–174,
2011.
[17] M. Thom, “Hippocampal sclerosis in epilepsy: a neuropathol-
ogy review,” Neuropathology and Applied Neurobiology,
vol. 40, no. 5, pp. 520–543, 2014.
[18] J. E. Kralic, D. A. Ledergerber, and J.-M. Fritschy, “Disruption
of the neurogenic potential of the dentate gyrus in a mouse
model of temporal lobe epilepsy with focal seizures,” The Euro-
pean Journal of Neuroscience, vol. 22, no. 8, pp. 1916–1927,
2005.
[19] B. Hattiangady, M. Rao, and A. Shetty, “Chronic temporal lobe
epilepsy is associated with severely declined dentate neurogen-
esis in the adult hippocampus,” Neurobiology of Disease,
vol. 17, no. 3, pp. 473–490, 2004.
[20] B. Hattiangady, M. S. Rao, and A. K. Shetty, “Grafting of
striatal precursor cells into hippocampus shortly after status
epilepticus restrains chronic temporal lobe epilepsy,” Exper-
imental Neurology, vol. 212, no. 2, pp. 468–481, 2008.
[21] B. K. McCabe, D. C. Silveira, M. R. Cilio et al., “Reduced neu-
rogenesis after neonatal seizures,” The Journal of Neuroscience,
vol. 21, no. 6, pp. 2094–2103, 2001.
[22] G. W. Mathern, J. L. Leiphart, A. de Vera et al., “Seizures
decrease postnatal neurogenesis and granule cell development
in the human fascia dentata,” Epilepsia, vol. 43, pp. 68–73,
2002.
[23] C. Heinrich, N. Nitta, A. Flubacher et al., “Reelin deficiency
and displacement of mature neurons, but not neurogenesis,
underlie the formation of granule cell dispersion in the epilep-
tic hippocampus,” The Journal of Neuroscience, vol. 26, no. 17,
pp. 4701–4713, 2006.
[24] A. Fahrner, G. Kann, A. Flubacher et al., “Granule cell disper-
sion is not accompanied by enhanced neurogenesis in tempo-
ral lobe epilepsy patients,” Experimental Neurology, vol. 203,
no. 2, pp. 320–332, 2007.
[25] L. D’Alessio, H. Konopka, E. M. López et al., “Doublecortin
(DCX) immunoreactivity in hippocampus of chronic refrac-
tory temporal lobe epilepsy patients with hippocampal sclero-
sis,” Seizure, vol. 19, no. 9, pp. 567–572, 2010.
[26] L. D’Alessio, H. Konopka, E. Escobar et al., “Dentate gyrus
expression of nestin-immunoreactivity in patients with drug-
resistant temporal lobe epilepsy and hippocampal sclerosis,”
Seizure, vol. 27, pp. 75–79, 2015.
[27] Z. S. Maglóczky, P. Halász, J. Vajda, S. Czirják, and T. F.
Freund, “Loss of Calbindin-D28K immunoreactivity from den-
tate granule cells in human temporal lobe epilepsy,” Neurosci-
ence, vol. 76, no. 2, pp. 377–385, 1997.
[28] J. I. Arellano, A. Muñoz, I. Ballesteros-Yañez, R. Sola, and
J. DeFelipe, “Histopathology and reorganization of chandelier
cells in the human epileptic sclerotic hippocampus,” Brain,
vol. 127, no. 1, pp. 45–64, 2004.
[29] O. von Bohlen und Halbach, “Immunohistological markers for
proliferative events, gliogenesis, and neurogenesis within the
10 Behavioural Neurology
adult hippocampus,” Cell and Tissue Research, vol. 345, no. 1,
pp. 1–19, 2011.
[30] D. S. Carter, A. J. Harrison, K.W. Falenski, R. E. Blair, and R. J.
DeLorenzo, “Long-term decrease in calbindin-D28K expres-
sion in the hippocampus of epileptic rats following
pilocarpine-induced status epilepticus,” Epilepsy Research,
vol. 79, no. 2-3, pp. 213–223, 2008.
[31] A. K. Shetty and B. Hattiangady, “Restoration of calbindin
after fetal hippocampal CA3 cell grafting into the injured hip-
pocampus in a rat model of temporal lobe epilepsy,” Hippo-
campus, vol. 17, no. 10, pp. 943–956, 2007.
[32] K. Karádi, J. Janszky, C. Gyimesi et al., “Correlation
between calbindin expression in granule cells of the resected
hippocampal dentate gyrus and verbal memory in temporal
lobe epilepsy,” Epilepsy & Behavior, vol. 25, no. 1, pp. 110–119,
2012.
[33] L. Martinian, C. B. Catarino, P. Thompson, S. M. Sisodiya, and
M. Thom, “Calbindin D28K expression in relation to granule
cell dispersion, mossy fibre sprouting and memory impair-
ment in hippocampal sclerosis: a surgical and post mortem
series,” Epilepsy Research, vol. 98, no. 1, pp. 14–24, 2012.
[34] H. Ábrahám, Z. Richter, C. Gyimesi et al., “Degree and pattern
of calbindin immunoreactivity in granule cells of the dentate
gyrus differ in mesial temporal sclerosis, cortical malforma-
tion- and tumor-related epilepsies,” Brain Research,
vol. 1399, pp. 66–78, 2011.
[35] A. Jouvenceau, B. Potier, F. Poindessous-Jazat et al., “Decrease
in calbindin content significantly alters LTP but not NMDA
receptor and calcium channel properties,” Neuropharmacol-
ogy, vol. 42, no. 4, pp. 444–458, 2002.
[36] T. C. Dumas, E. C. Powers, P. E. Tarapore, and R. M. Sapolsky,
“Overexpression of calbindin D28K in dentate gyrus granule
cells alters mossy fiber presynaptic function and impairs
hippocampal-dependent memory,” Hippocampus, vol. 14,
no. 6, pp. 701–709, 2004.
[37] S. Oddo, P. Solis, D. Consalvo et al., “Postoperative neuropsy-
chological outcome in patients with mesial temporal lobe epi-
lepsy in Argentina,” Epilepsy Research and Treatment,
vol. 2012, Article ID 370351, 5 pages, 2012.
[38] P. Kwan, A. Arzimanoglou, A. T. Berg et al., “Definition of
drug resistant epilepsy: consensus proposal by the ad hoc Task
Force of the ILAE Commission on Therapeutic Strategies,”
Epilepsia, vol. 51, no. 6, pp. 1069–1077, 2010.
[39] L. D’Alessio, B. Giagante, C. Papayannis et al., “Psychotic dis-
orders in Argentine patients with refractory temporal lobe epi-
lepsy: a case-control study,” Epilepsy & Behavior, vol. 14, no. 4,
pp. 604–609, 2009.
[40] L. D’Alessio, B. Giagante, S. Oddo et al., “Psychiatric disorders
in patients with psychogenic non-epileptic seizures, with and
without comorbid epilepsy,” Seizure, vol. 15, no. 5, pp. 333–
339, 2006.
[41] M. D. Lezak, Neuropschychogical Assessment, Oxford Univer-
sity Press, Third edition, 1995.
[42] B. Giagante, S. Oddo, W. Silva et al., “Clinical-electroencepha-
logram patterns at seizure onset in patients with hippocampal
sclerosis,” Clinical Neurophysiology, vol. 114, no. 12, pp. 2286–
2293, 2003.
[43] P. Campo and M. Morales, “Normative data and reliability for
a Spanish version of the verbal selective reminding test,”
Archives of Clinical Neuropsychology, vol. 19, no. 3, pp. 421–
435, 2004.
[44] L. D'Alessio, L. Scévola, M. Fernandez Lima et al., “Psychi-
atric outcome of epilepsy surgery in patients with psycho-
sis and temporal lobe drug-resistant epilepsy: a prospective
case series,” Epilepsy & Behavior, vol. 37, pp. 165–170,
2014.
[45] M. First, M. Gibbon, R. Spitzer, J. Williams, and L. Smith,
Entrevista Clínica Estructurada para los Trastornos del Eje I
del DSM-IV (SCID I), Barcelona, Spain, 1999.
[46] M. First, M. Gibbon, R. Spitzer, J. Williams, and L. Smith,
Entrevista Clínica Estructurada para los Trastornos del Eje II
del DSM-IV (SCID II), MASSON S.A, Barcelona, Spain, 1999.
[47] American Psychiatric Association, Diagnostic and Statistical
Manual of Mental Disorders. DSM IV, American Psychiatric
Asocciation, Washington, DC, USA, 4th edition, 1994.
[48] L.-W. Kuo, C.-Y. Lee, J.-H. Chen et al., “Mossy fiber
sprouting in pilocarpine-induced status epilepticus rat hip-
pocampus: a correlative study of diffusion spectrum imag-
ing and histology,” NeuroImage, vol. 41, no. 3, pp. 789–
800, 2008.
[49] L. Kandratavicius, J. E. Hallak, L. T. Young, J. A. Assirati, C. G.
Carlotti Jr., and J. P. Leite, “Differential aberrant sprouting in
temporal lobe epilepsy with psychiatric co-morbidities,” Psy-
chiatry Research, vol. 195, no. 3, pp. 144–150, 2012.
[50] H. E. Scharfman and H. L. Bernstein, “Potential implications
of a monosynaptic pathway from mossy cells to adult-born
granule cells of the dentate gyrus,” Frontiers in Systems Neuro-
science, vol. 9, p. 112, 2015.
[51] L. J. Drew, M. A. Kheirbek, V. M. Luna et al., “Activation
of local inhibitory circuits in the dentate gyrus by adult-
born neurons,” Hippocampus, vol. 26, no. 6, pp. 763–778,
2016.
[52] A. A. Lempel, L. Coll, A. F. Schinder, O. D. Uchitel, and J. Piriz,
“Chronic pregabalin treatment decreases excitability of den-
tate gyrus and accelerates maturation of adult-born granule
cells,” Journal of Neurochemistry, vol. 140, no. 2, pp. 257–
267, 2017.
[53] U. V. Nägerl, I. Mody, M. Jeub, A. A. Lie, C. E. Elger, and
H. Beck, “Surviving granule cells of the sclerotic human
hippocampus have reduced Ca2+ influx because of a loss
of calbindin-D28k in temporal lobe epilepsy,” The Journal
of Neuroscience, vol. 20, no. 5, pp. 1831–1836, 2000.
[54] J.-T. Li, X. M. Xie, J. Y. Yu et al., “Suppressed calbindin
levels in hippocampal excitatory neurons mediate stress-
induced memory loss,” Cell Reports, vol. 21, no. 4,
pp. 891–900, 2017.
[55] A. M. Kanner, “Depression and epilepsy: a bidirectional rela-
tion?,” Epilepsia, vol. 52, pp. 21–27, 2011.
[56] A. M. Kanner, “Most antidepressant drugs are safe for patients
with epilepsy at therapeutic doses: a review of the evidence,”
Epilepsy & Behavior, vol. 61, pp. 282–286, 2016.
[57] P. J. Lucassen, P. Meerlo, A. S. Naylor et al., “Regulation of
adult neurogenesis by stress, sleep disruption, exercise and
inflammation: implications for depression and antidepres-
sant action,” European Neuropsychopharmacology, vol. 20,
no. 1, pp. 1–17, 2010.
[58] B. Hattiangady and A. K. Shetty, “Implications of decreased
hippocampal neurogenesis in chronic temporal lobe epilepsy,”
Epilepsia, vol. 49, Supplement 5, pp. 26–41, 2008.
[59] H. Karst andM. Joëls, “Effect of chronic stress on synaptic cur-
rents in rat hippocampal dentate gyrus neurons,” Journal of
Neurophysiology, vol. 89, no. 1, pp. 625–633, 2003.
11Behavioural Neurology
[60] F. L. Groeneweg, H. Karst, E. R. de Kloet, and M. Joëls, “Min-
eralocorticoid and glucocorticoid receptors at the neuronal
membrane, regulators of nongenomic corticosteroid signal-
ling,” Molecular and Cellular Endocrinology, vol. 350, no. 2,
pp. 299–309, 2012.
[61] E. R. de Kloet, C. Otte, R. Kumsta et al., “Stress and depression
a crucial role of the mineralocorticoid receptor,” Journal of
Neuroendocrinology, vol. 28, no. 8, pp. 1–12, 2016.
[62] Y. I. Sheline, P. W. Wang, M. H. Gado, J. G. Csernansky, and
M. W. Vannier, “Hippocampal atrophy in recurrent major
depression,” Proceedings of the National Academy of Sciences
of the United States of America, vol. 93, no. 9, pp. 3908–3913,
1996.
[63] C. Anacker and R. Hen, “Adult hippocampal neurogenesis and
cognitive flexibility — linking memory and mood,” Nature
Reviews Neuroscience, vol. 18, no. 6, pp. 335–346, 2017.
[64] B. S. McEwen and P. J. Gianaros, “Stress- and allostasis-
induced brain plasticity,” Annual Review of Medicine, vol. 62,
no. 1, pp. 431–445, 2011.
[65] I. N. Karatsoreos and B. S. McEwen, “Resilience and vulnera-
bility: a neurobiological perspective,” F1000Prime Reports,
vol. 5, p. 13, 2013.
[66] L. Kandratavicius, J. Peixoto-Santos, M. Monteiro et al.,
“Mesial temporal lobe epilepsy with psychiatric comorbidities:
a place for differential neuroinflammatory interplay,” Journal
of Neuroinflammation, vol. 12, no. 1, p. 38, 2015.
[67] N. A. Datson, J. M. E. van den Oever, O. B. Korobko, A. M.
Magarinos, E. R. de Kloet, and B. S. McEwen, “Previous history
of chronic stress changes the transcriptional response to gluco-
corticoid challenge in the dentate gyrus region of the male rat
hippocampus,” Endocrinology, vol. 154, no. 9, pp. 3261–3272,
2013.
[68] C. Nasca, D. Zelli, B. Bigio et al., “Stress dynamically regulates
behavior and glutamatergic gene expression in hippocampus
by opening a window of epigenetic plasticity,” Proceedings of
the National Academy of Sciences of the United States of Amer-
ica, vol. 112, no. 48, pp. 14960–14965, 2015.
[69] E. Aronica, K. Fluiter, A. Iyer et al., “Expression pattern of
miR-146a, an inflammation-associated microRNA in experi-
mental and human temporal lobe epilepsy,” European Journal
of Neuroscience, vol. 31, no. 6, pp. 1100–1107, 2010.
[70] Y.-K. Kim, K. S. Na, A. M. Myint, and B. E. Leonard, “The role
of pro-inflammatory cytokines in neuroinflammation, neuro-
genesis and the neuroendocrine system in major depression,”
Progress in Neuro-Psychopharmacology and Biological Psychia-
try, vol. 64, pp. 277–284, 2016.
[71] E. Pauli, M. Hildebrandt, J. Romstock, H. Stefan, and
I. Blümcke, “Deficient memory acquisition in temporal lobe
epilepsy is predicted by hippocampal granule cell loss,” Neu-

















































































Submit your manuscripts at
www.hindawi.com
